Evidence map›Paper›PMID 24397362›Full record

ArticleACS chemical neuroscience2014

Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.

Martin Hansen, Karina Phonekeo, James S Paine, Sebastian Leth-Petersen, Mikael Begtrup, Hans Bräuner-Osborne, Jesper L Kristensen

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. ACS omega · 2026
    Article
  2. Article
  3. Article
  4. Discovery of Highly Selective 5-HTJournal of medicinal chemistry · 2025
    Article
  5. Serotonin receptor 5-HTJournal for immunotherapy of cancer · 2025
    Article
  6. The Selective Serotonin 5‑HTACS pharmacology & translational science · 2025
    Article
  7. Article
  8. Article
  9. The Selective 5HTSynapse (New York, N.Y.) · 2025
    Article
  10. Article
  11. Article
  12. Psychedelic enhancement of flexible learning weeks after a single dose.bioRxiv : the preprint server for biology · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Identification of 5-HTNature communications · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. On the construction of LIECE models for the serotonin receptor 5-HTJournal of computer-aided molecular design · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martin HansenDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, 2100 København Ø, Denmark.
Karina Phonekeo
James S Paine
Sebastian Leth-Petersen
Mikael Begtrup
Hans Bräuner-Osborne
Jesper L Kristensen

Funding

PHS HHS HHSN-271-2008-00025-C
6 · The paper itself

Abstract

N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor. We have prepared a series of 48 compounds with structural variations in both the phenethylamine and N-benzyl part of the molecule to determine the effects on receptor binding affinity and functional activity at 5-HT2A and 5-HT2C receptors. The compounds generally had high affinity for the 5-HT2A receptor with 8b having the highest affinity at 0.29 nM but with several other compounds also exhibiting subnanomolar binding affinities. The functional activity of the compounds was distributed over a wider range with 1b being the most potent at 0.074 nM. Most of the compounds exhibited low to moderate selectivity (1- to 40-fold) for the 5-HT2A receptor in the binding assays, although one compound 6b showed an impressive 100-fold selectivity for the 5-HT2A receptor. In the functional assay, selectivity was generally higher with 1b being more than 400-fold selective for the 5-HT2A receptor.

Indexed as

Binding, CompetitiveDose-Response Relationship, DrugHEK293 CellsHumansInositol PhosphatesMolecular StructurePhenethylaminesRadioligand AssayReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AgonistsInositol PhosphatesPhenethylaminesReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor Agonists

Identifiers

PMID24397362
PMCPMC3963123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.